Table 3. Adverse events that occurred during the hospitalization of the 78 patients with recent-onset atrial fibrillation (group A: cardioversion by intravenous administration of vernakalant, group B: cardioversion by intravenous administration of ibutilide).

Values are given as number of events occurred (percentage in brackets), VT: ventricular tachycardia.